Liquid Biopsy Is New Technique That Holds Promising Future To Revolutionize Cancer Care

 

Liquid Biopsy

A Liquid Biopsy is a form of cancer detection that provides real-time information about a tumor. This information is obtained by taking a blood sample, separating the blood cells from the plasma, and testing the liquid for genetic and molecular changes. The results of the test can tell the provider whether or not the patient is responding to treatment, and which treatments are likely to be most effective.

Liquid biopsies are a less invasive and more economical method of identifying a patient with cancer. Liquid Biopsy can also be used to detect disease recurrence or monitor the response to treatments. However, they can be less accurate than targeted therapies. Unlike tissue-based testing, they are less precise and may not be able to detect all mutations throughout a tumor.

A number of FDA-approved assays are available for use in Liquid Biopsy tests. These include those that examine circulating tumor DNA (ctDNA) and non-coding RNA. In addition, there are several assays that are considered sufficient by insurance companies for treatment eligibility. Some of these assays are available commercially, while others are in clinical trials.

It is useful for monitoring patients with cancer because it can identify low-level recurrences of the disease. It can also be used to detect specific mutations in the cancer cell's DNA. Detecting these genetic errors can be helpful in deciding which treatment is best for a given patient.

Earlier detection of cancer can lead to improved survival rates. If detected early, a patient may be able to take advantage of targeted therapy to destroy specific types of cancer cells. Similarly, an early diagnosis of the disease will allow the healthcare provider to adjust the course of treatment as needed. Although a Liquid Biopsy is a relatively new tool, it holds the potential to revolutionize cancer care. It can be a safe and effective alternative to tissue-based testing, allowing doctors to perform several biopsies to better understand the extent of the tumor's damage. At the same time, it is easier and less invasive than tissue-based testing, which can be complicated and costly.

Comments

Popular posts from this blog

With the use of High-Frequency alternating current, Radiofrequency Ablation Device convert Electromagnetic Energy into Heat Energy

The Isocyanates Market to Witness Robust Growth in North America and Asia Pacific

Air Purifier works as a Sanitizer in the air which helps in reducing pollutants, allergens, and toxins